Rocket Pharmaceuticals (NASDAQ:RCKT) Receives “Hold” Rating from Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat reports. They currently have a $42.00 target price on the biotechnology company’s stock. RCKT has been the topic of a number of other research reports. Canaccord Genuity […]
Needham & Company LLC reaffirmed their hold rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat reports. They currently have a $42.00 target price on the biotechnology company’s stock. RCKT has been the topic of a number of other research reports. Canaccord Genuity […]
